Univest
Univest
  • Markets
  • Alembic Ltd Analyst Review 2027: Stake in Alembic Pharma Worth More Than Its Own Market Value

    • November 19, 2026
    • Posted by: Chaitanya Auti
    • Category: Market
    No Comments
    Alembic Ltd Analyst Review 2027: Stake in Alembic Pharma Worth More Than Its Own Market Value

    Alembic Ltd earned ₹67.57 crore in Q2 FY27, down 11% from a year ago, but its 28.5% stake in Alembic Pharmaceuticals alone is worth about twice its own market value. With no brokerage coverage, we review results, the holding structure, valuation and key risks.

    read more